StartUp Health January 6, 2026
Nicole Kinsey

Spanning China, Israel, India, the US, Japan, South Korea, and the UK, the year’s first funding report captures a powerful continuation of late-December investment activity, with raises fueling breakthroughs in AI-driven research, cardiovascular care, cancer diagnostics, telehealth, and global public health innovation.

This week’s reported global health innovation funding included:

DP Technology, a Beijing, China-based startup that uses its AI tools to accelerate scientific research in everything from laboratory automation to drug development, raised 800M yuan ($114M) led by Fortune Venture Capital and the Beijing Jingguorui Equity Investment Fund, with participation from the Beijing Artificial Intelligence Industry Investment Fund, Beijing Pharmaceutical and Health Industry Investment Fund, Lenovo Capital, Incubator Group, and Oriza Hua. <source>

Biobeat Technologies, a Petah Tikva, Israel-...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Investments, Trends
Related Articles:
Biotech investor Cormorant secures $150M for another SPAC deal
AI Startups Hit Unicorn Status at Seed Stage
VieCure Raises $43 Million to Help Democratize Access | Avalon Healthcare Solutions Announces Strategic Investment
Synthesia raises $200M, with $4B valuation
AnswersNow Raises $40M to Expand Access to Autism Therapy

Share Article